Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
doi:10.1097/ALN.0b013e318178820b
Diabetes 68(1):3444
This study aimed to compare the effectiveness and safety of LY3298176 with a placebo and with dulaglutide, a drug that stimulates only the GLP-1 receptor
however, compared to CAF, PXN has higher binding potency for adenosine A1 and A2A receptors and produces more substantial locomotor activation effects (Orr et al
US$ 21.64
US$ 21.52
US$ 25.73
US$ 28.96
US$ 24.45
US$ 24.51
US$ 21.99
US$ 22.12
US$ 23.84
